Though multiple factors are associated with diabetic dyslipidemia, it has been shown in some studies that apoB production by the liver is elevated in T2DM patients, which is related to an increase in LDL levels and non-HDL-cholesterol levels, correlating to a higher risk of cardiovascular diseases (CVDs). The gene discussed is APOB; the disease is cardiovascular disorder.